Advertisement

Topics

The Lupus Foundation of America Greater Washington Company Profile

21:46 EDT 21st September 2018 | BioPortfolio


News Articles [1457 Associated News Articles listed on BioPortfolio]

Smaller, shorter trials, more flexibility needed for lupus treatment development

Joan T. MerrillThe current standard of lupus disease control is unacceptable, and smaller and shorter drug trials are required to develop more effective treatments, according to a white paper publishe...

May is Lupus Awareness Month

Systemic Lupus Erythematosus (SLE or Lupus) is an autoimmune disease in which the immune system produces antibodies to cells within the body, leading to widespread inflammation and tissue damage. Whil...

Lupus Research Alliance And Lupus Therapeutics Collaborate With Bristol-Myers Squibb

NewsThe Lupus Research Alliance announced a collaboration between its newly formed affiliate, Lupus Therapeutics, and the pharmaceutical company, Bristol-Myers Squibb (BMS), to test a novel investigat...

Belimumab Aids Anti-dsDNA+, Hypocomplementemic Lupus

MONDAY, April 23, 2018 -- Weekly belimumab is associated with greater benefit than placebo for patients with hypocomplementemic/anti-double stranded (ds)DNA-positive systemic lupus erythematosus (SLE)...

Medical News Today: What is the link between lupus and arthritis?

Lupus and arthritis are separate conditions. However, arthritis is one of the most common symptoms of lupus. There may also be a genetic link between rheumatoid arthritis and lupus. In this article, w...

Fellowships offer reporters valuable insight as America ages

(The Gerontological Society of America) The Gerontological Society of America (GSA) Journalists in Aging Fellows Program has received renewed grant support to welcome its ninth cohort of reporters. Th...

BMS forms collaboration to study lupus drug

Bristol-Myers Squibb (BMS) has partnered with Lupus Research Alliance and Lupus Therapeutics to evaluate a new investigational therapy, BMS-986165, for...Read More... The post BMS forms collaboration ...

Ablynx's AbbVie-Partnered Lupus Candidate Hits End Of Road

Ablynx's IL-6 inhibitor has reached the end of the road in lupus; failure of the Phase II STEADY trial is...   

Drugs and Medications [689 Associated Drugs and Medications listed on BioPortfolio]

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

Shiseido white lucent brightening spot-control foundation (refill) [SHISEIDO AMERICA INC.]

SHISEIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill)

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

PubMed Articles [1570 Associated PubMed Articles listed on BioPortfolio]

Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013.

Mortality due to rare diseases, which are substantial sources of premature mortality, is underreported in mortality studies. The objective of this study was to determine the completeness of reporting ...

A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus.

Lupus erythematosus tumidus (LET) is an uncommon type of cutaneous lupus erythematosus (CLE) that is rarely associated with other forms of lupus erythematosus.

Oxidative stress and dietary micronutrient deficiencies contribute to overexpression of epigenetically regulated genes by lupus T cells.

Patients with active lupus have altered T cells characterized by low DNA methyltransferase levels. We hypothesized that low DNA methyltransferase levels synergize with low methionine levels to cause g...

Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors.

Depression and anxiety cause severe loss of quality of life for patients with systemic lupus erythematosus. The causes and factors that contribute to these psychological manifestations in lupus are di...

Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.

Autoimmune haemolytic anaemia (AIHA) and autoimmune thrombocytopenia are common complications of childhood-onset lupus, which may be life-threatening. A greater understanding of the pathogenesis of th...

Clinical Trials [2483 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus

This is a Phase II, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of rontalizumab compared with placebo in patients with moderately to ...

Duke Lupus Registry

Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common...

An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)

This trial is conducted in Europe and North America. The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetic and signs of bioactivity of increasing singl...

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

This trial is conducted in the United States of America (USA). The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetics and signs of bioactivity of incre...

Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus

This clinical study will test the efficacy and safety of nicotinamide for lupus-associated skin lesions refractory to the treatment of hydroxychloroquine plus low-dose corticosteroids in p...

Companies [3263 Associated Companies listed on BioPortfolio]

The Lupus Foundation of America Greater Washington

Lupus Foundation of America Greater Washington Chapter, Inc.

Lupus Foundation of America Greater Washington Chapter

Lupus Foundation of America (LFA)

The Lupus Foundation of America (LFA) is the foremost national nonprofit organization dedicated to finding the causes of and cure for lupus, and providing support, services, and h...

S.L.E. Lupus Foundation

The S.L.E. Lupus Foundation, headquartered in New York City with a West Coast division in Los Angeles, is the country's preeminent nonprofit organization providing direct patient services, education, ...

More Information about "The Lupus Foundation of America Greater Washington" on BioPortfolio

We have published hundreds of The Lupus Foundation of America Greater Washington news stories on BioPortfolio along with dozens of The Lupus Foundation of America Greater Washington Clinical Trials and PubMed Articles about The Lupus Foundation of America Greater Washington for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Lupus Foundation of America Greater Washington Companies in our database. You can also find out about relevant The Lupus Foundation of America Greater Washington Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record